Bridging the Gap: Inclusion of Pregnant Women in Clinical Drug Trials
Clin Chem. 2025 Dec 30;72(1):7-10. doi: 10.1093/clinchem/hvaf149. NO ABSTRACT PMID:41468139 | DOI:10.1093/clinchem/hvaf149

Clin Chem. 2025 Dec 30;72(1):7-10. doi: 10.1093/clinchem/hvaf149. NO ABSTRACT PMID:41468139 | DOI:10.1093/clinchem/hvaf149
Clin Chem. 2025 Dec 30;72(1):133-139. doi: 10.1093/clinchem/hvaf158. ABSTRACT BACKGROUND: Congenital heart defects (CHDs) are the most prevalent birth defects, contributing significantly to infant morbidity and mortality. While genetic factors account for a subset of CHDs, environmental exposures during critical periods of cardiac development are increasingly recognized as potential contributors. CONTENT: This review synthesizes current evidence … Read more
Clin Chem. 2025 Dec 30;72(1):11-15. doi: 10.1093/clinchem/hvaf125. NO ABSTRACT PMID:41468137 | DOI:10.1093/clinchem/hvaf125
Clin Chem. 2025 Dec 30;72(1):123-132. doi: 10.1093/clinchem/hvaf148. ABSTRACT BACKGROUND: Newborn screening (NBS) is a foundational public health program designed to identify severe but treatable conditions in presymptomatic newborns. Since Robert Guthrie introduced the phenylketonuria test in the 1960s, NBS has evolved from single-condition assays to multiplex platforms, enabling early diagnosis, intervention, and long-term follow-up. Understanding … Read more
Clin Chem. 2025 Dec 30;72(1):173-182. doi: 10.1093/clinchem/hvaf159. ABSTRACT BACKGROUND: Congenital cytomegalovirus (cCMV) infection is a leading cause of sensorineural hearing loss in children. Recent evidence that high-dose valacyclovir reduces vertical transmission following primary maternal infection has renewed the urgency for screening. We investigated the utility of quantifying cell-free CMV DNA from noninvasive prenatal screening (NIPS) … Read more
Clin Chem. 2025 Dec 22:hvaf171. doi: 10.1093/clinchem/hvaf171. Online ahead of print. NO ABSTRACT PMID:41427994 | DOI:10.1093/clinchem/hvaf171
Clin Chem. 2025 Dec 19:hvaf156. doi: 10.1093/clinchem/hvaf156. Online ahead of print. ABSTRACT BACKGROUND: The safety and efficacy of fecal microbiota transplantation for prevention of recurrent Clostridioides difficile infection relies on complex interactions between the donor and recipient microbiome. CONTENT: Screening of donor stool has largely aimed to ensure safety; however, metagenomic and metabolic features of … Read more
Clin Chem. 2025 Dec 19:hvaf184. doi: 10.1093/clinchem/hvaf184. Online ahead of print. NO ABSTRACT PMID:41417459 | DOI:10.1093/clinchem/hvaf184
Clin Chem. 2025 Dec 16:hvaf166. doi: 10.1093/clinchem/hvaf166. Online ahead of print. ABSTRACT BACKGROUND: Serum uromodulin (SUmod) and carbamylated albumin (C-Alb) are emerging biomarkers for chronic kidney disease (CKD) progression and mortality. SUmod reflects tubular health, while C-Alb is associated with excretory kidney function, CKD progression, and cardiovascular (CV) mortality. We hypothesized that the combined use … Read more
Clin Chem. 2025 Dec 16:hvaf170. doi: 10.1093/clinchem/hvaf170. Online ahead of print. NO ABSTRACT PMID:41400225 | DOI:10.1093/clinchem/hvaf170